Skip to main content

A Phase 3 Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Efficacy and safety of Rebiotix RBX2660 (microbiota suspension) for the Prevention of Recurrent Clostridium difficile Infection

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Rebiotix Inc.

Start Date

June 19, 2019

End Date

November 19, 2021
 

Administered By

Medicine, Gastroenterology

Awarded By

Rebiotix Inc.

Start Date

June 19, 2019

End Date

November 19, 2021